Last updated: March 11, 2026
This content is for educational purposes only and is not veterinary advice. Always consult a licensed equine veterinarian for diagnosis or treatment. Lasix and HISA rules are time-sensitive; verify local regulations. External links were active as of March 5, 2026.
I’ve been a licensed Thoroughbred owner in Louisiana for more than 30 years — Fair Grounds and Delta Downs have been my primary tracks, claiming races my specialty. In that time, I’ve seen everything the sport can throw at a horse. But there is one sight that still stops me cold: walking into the receiving barn after a race and finding blood at a horse’s nostrils.
What you’re seeing — in most cases — is not a nosebleed in the conventional sense. It’s the visible end of a process that started deep inside the lung tissue, where microscopic capillaries rupture under the extraordinary cardiovascular pressures a galloping Thoroughbred generates during racing. The condition is called Exercise-Induced Pulmonary Hemorrhage, or EIPH. It affects roughly 74% of racehorses to some measurable degree, yet most owners never know it’s happening because most EIPH produces no visible blood at all.
This article answers the question completely: why do racehorses bleed from the lungs, what it means for performance and welfare, how Lasix works as a treatment, what the 2026 HISA regulatory environment means for owners and bettors, and what you should do if your horse bleeds. Educational only — consult your licensed equine veterinarian for any diagnosis or treatment decisions.
- 74% of Thoroughbreds show detectable lung bleeding via endoscopy after racing (ACVIM/PMC data).
- Only 1–5% of starts produce a visible nosebleed — most EIPH is subclinical and invisible without scoping.
- A 2024 Equine Veterinary Journal study found Lasix reduces EIPH severity by approximately 70%.
- Lasix can cause horses to shed 15–30 lbs of fluid before a race — that pre-race heavy urination is the treatment working.
- Bettor angle: First-time Lasix runners with a documented late-race fade pattern show legitimate performance rebounds — see the filter table below.
Table of Contents
What Is EIPH? The Science Behind 74% Prevalence
Exercise-Induced Pulmonary Hemorrhage is bleeding within the lungs triggered by intense physical exertion. It is not an infection, not a disease horses catch from each other, and not a sign of neglect. It is a physiological consequence of equine anatomy combined with the extraordinary cardiovascular demands of racing. The 2015 ACVIM consensus statement classifies EIPH as a medical condition and confirms that furosemide (Lasix) is effective in reducing both its incidence and severity.
During a race, a Thoroughbred’s heart can pump up to 75 liters of blood per minute. Pulmonary arterial pressure spikes to levels that the delicate capillaries lining the alveoli — the tiny air sacs where oxygen enters the bloodstream — cannot sustain without rupturing. Blood enters the airways and, in severe cases, becomes visible at the nostrils. The 74% prevalence figure comes from endoscopic studies: when vets scope horses within 30–90 minutes of racing, nearly three in four show some blood in the airway. But most are minor Grade 1 events that never produce a visible nosebleed.
Deep Dive: How Pulmonary Capillary Stress Failure Works (For Veterinary & Technical Readers)
At peak racing speed, mean pulmonary artery pressure rises from approximately 15–20 mmHg at rest to 90–120 mmHg or higher during maximal exertion. Horses are obligate nasal breathers — unlike humans, they cannot open their mouths to draw supplemental air — meaning the respiratory system cannot buffer cardiovascular demand independently.
The mechanism of capillary rupture is classified as stress failure of pulmonary capillaries: when transmural pressure exceeds the tensile strength of the capillary wall, it tears. Red blood cells escape into the alveolar space, where they degrade over time into hemosiderin. Repeated EIPH episodes cause progressive hemosiderin deposition and, eventually, pulmonary fibrosis — scar tissue that reduces lung capacity and increases future EIPH risk.
Research published in a 2024 PMC study reinforced that EIPH is structural and hemodynamic, not simply a management problem. Bronchoalveolar lavage (BAL) — collecting fluid from the lower airways — and endoscopic grading within 30–90 minutes post-race are the gold-standard diagnostic tools.
For the full picture of how Lasix urination connects to EIPH treatment, see our companion piece: Why Do Racehorses Pee So Much? — the heavy pre-race urination you see in the receiving barn is direct, visible evidence that the medication is actively lowering pulmonary vascular pressure.
Why Racing Causes Lung Bleeding: Not All Bleeders Are Equal
The biomechanics of a galloping horse create a perfect storm for pulmonary bleeding. At Fair Grounds and Delta Downs, I’ve watched horses come back from a race looking perfectly fine — then get scoped and show Grade 2 blood in the trachea. Others bleed visibly and dramatically. The underlying mechanics are the same; the severity depends on multiple converging factors.
Locomotion-breathing coupling. Horses synchronize each stride with a single breath at the gallop — one breath per stride, no exceptions. The respiratory system cannot independently regulate pressure during peak effort. Every stride compresses and decompresses the chest cavity in lockstep with cardiovascular demand. There is no breathing buffer.
Race distance, surface, and weather. Sprint races produce peak pulmonary pressure faster but for shorter duration. Cold, damp air — common at Fair Grounds in January and February — increases airway reactivity and appears to worsen EIPH episodes, consistent with research on cold-air inhalation and bronchospasm. These environmental factors explain why I see more bleeds during the Fair Grounds winter meet than during the spring meet on similar horses.
Cumulative lung damage. Each EIPH episode — even subclinical Grade 1 events — deposits hemosiderin in the lung tissue. Over racing seasons this contributes to fibrosis that reduces lung capacity and makes future bleeding worse. A confirmed bleeder at age 4 almost always has more severe EIPH by age 6 without management. For context on the broader physical toll of racing, see our racehorse injury overview and fluid loss during racing guide.
Additional EIPH Risk Factors: Trainers & Owners Reference
- Upper respiratory tract infections or lingering viral inflammation (EIV, EHV)
- Poor barn air quality: dust, ammonia, mold — especially closed stalls in winter
- Frequent racing with short recovery windows between starts
- Genetic predisposition — certain bloodlines show higher EIPH prevalence
- Older horses with accumulated lung fibrosis from prior episodes
- High-altitude racing environments
- Sprint distances at maximum effort without an adequate fitness base
See also: thermoregulatory stress during racing for the broader physiological picture.
How Lasix Prevents EIPH — And Why Heavy Pre-Race Urination Matters
Furosemide (Lasix) is a loop diuretic. The mechanism relevant to EIPH prevention isn’t the urination itself — it’s what the urination causes: a significant reduction in circulating blood volume, which lowers pulmonary vascular pressure before the race begins. Lower pressure at peak cardiovascular demand means less stress on those fragile pulmonary capillaries.
Administered by the track veterinarian approximately 4 hours before post time, Lasix triggers the horse to urinate 10–15 liters (3–4 gallons) within hours — shedding 15–30 pounds of body weight. That’s the heavy pre-race urination you see in the receiving barn: direct, visible evidence the medication is active. By race time, pulmonary arterial pressure at peak effort is measurably lower than it would be without treatment.
The landmark Hinchcliff randomized controlled trial demonstrated that pre-race furosemide decreases both the incidence and severity of EIPH versus placebo. The ACVIM 2015 consensus statement confirmed furosemide is efficacious for EIPH management. A 2024 PMC study quantified approximately 70% reduction in EIPH severity with Lasix use. The WSU 2024 study analyzing approximately 30,000 horses is specifically investigating whether Lasix correlates with longer racing careers — results are pending before the May 22, 2026 HISA vote.
The controversy is real: a horse racing 20–30 pounds lighter may also be faster, which raises the performance-enhancement argument. Supporters counter that treating a horse that would otherwise bleed internally during a race is an ethical obligation, not a performance tactic. The veterinary consensus on efficacy for EIPH reduction is not seriously disputed. For the full regulatory and historical context, see our complete Lasix in horse racing guide.
EIPH Severity Grades and Race Impact: Grade 0 Through Grade 4 Explained
EIPH is graded endoscopically on a 0–4 scale. Understanding the grades matters enormously: a Grade 1 horse and a Grade 4 horse are fundamentally different risk profiles for owners, trainers, and bettors.
| EIPH Grade | What Veterinarians See (Endoscope Exam) | Typical Effect on Performance | Welfare Concern Level |
|---|---|---|---|
| Grade 0 | No visible blood in the trachea after exercise | No measurable impact | None |
| Grade 1 | Small flecks or a single narrow stream of blood | Mild fatigue possible late in race | Low |
| Grade 2 | Two or more distinct streams of blood | Often fades in the final stretch | Moderate |
| Grade 3 | Blood covering much of the trachea | Significant performance decline | High |
| Grade 4 | Large amounts of blood; may exit nostrils | Severe impairment | Immediate veterinary concern |
When a race chart notes a horse was “vanned off” or “pulled up” with no obvious injury, a Grade 3–4 bleed is frequently the cause. For context on managing horses after difficult races, see our piece on why racehorses are walked after a race.
Diamond Country was a $5,000 claimer I’d brought along for two seasons at Delta Downs. Tuesday workout: career-best five-furlong time. Friday race: cold January afternoon, damp dirt. She ran dead last — then bled visibly from both nostrils in the receiving barn. Not a trickle. Real blood. My track vet scoped her that afternoon and confirmed Grade 3 EIPH with significant blood pooling in the lower trachea.
We gave her 45 days rest, started her on Lasix for her next start, and she ran second at 12-1. The Lasix wasn’t magic. What it did was reduce the pulmonary pressure enough that she could finish the race without bleeding shutting her down in the final furlong. Before that, I thought she was quitting. She wasn’t — she was struggling to breathe through bleeding lungs.
The lesson I share with every new owner at my barn: if your horse has a quitting pattern in the stretch and hasn’t been scoped, scope them before you change trainers or drop in class. EIPH is invisible until it isn’t.
2026 HISA Lasix Rules: Stakes and 2-Year-Old Ban — Claiming Owners, Read This
The Horseracing Integrity and Safety Act made the most consequential change to EIPH management in U.S. racing history: furosemide is now banned in all stakes races and all 2-year-old races. The horses most visible to casual fans — graded stakes runners and the juvenile crop — are racing without the primary pharmacological tool vets have used for decades to manage lung bleeding. Three commissioned research projects were delivered to HISA’s Furosemide Advisory Committee in January 2026, and the board’s decisive vote is scheduled for May 22, 2026.
Under the Act’s structure, the board must vote unanimously to maintain any form of permitted Lasix use. If that unanimous threshold is not reached, a complete ban on race-day furosemide in all U.S. Thoroughbred racing takes effect automatically, per TDN’s February 2026 coverage. The WSU study analyzing approximately 30,000 horses is one of the three projects informing that vote.
The real-world effects of the existing partial ban are already documented. A Winter 2026 NYTHA survey found 47% of horsemen have seen increased EIPH incidences in 2-year-olds since the ban took effect, 80% have bypassed a stakes race specifically to keep a horse Lasix-eligible in an overnight race, and 81% would race less if the ban extends to all races. At Fair Grounds, I’ve watched trainers scratch confirmed bleeders from the Risen Star undercard specifically to protect their Lasix eligibility in a $25,000 claimer the following week. For how class levels intersect with medication rules, see our class levels guide and claiming race overview.
The HISA stakes ban created a two-tier medication landscape that claiming owners can use right now. In Louisiana’s overnight claiming ranks — $8,000 to $25,000 — Lasix remains permitted under the current waiver. A confirmed Grade 2 bleeder who can’t run stakes without Lasix is no less valuable at the claiming level. In some cases that horse is more predictable: you know the condition, you know it’s managed, and the competition at that level includes plenty of horses with hidden problems.
When I see a “BL” notation in a horse’s Daily Racing Form past performances, I don’t automatically pass. I look at the bleed grade, the rest period, whether they came back on Lasix, and how their speed figures trended post-bleed. A horse that bled Grade 2, had 45 days rest, returned on Lasix, and ran two consecutive solid numbers? That’s a managed condition — not a death sentence.
My 12 Bleeder Claims at Fair Grounds and Delta Downs: Outcomes Data
Four Miles’ Takes gives you the narrative. Here is the aggregate. Over the past 12 years, I have claimed 12 horses with documented EIPH history. The table below summarizes outcomes by bleed grade, rest period, and Lasix status — the closest thing to a personal case series I can offer. It is not a controlled study; it’s 12 horses in the Louisiana claiming ranks. But the patterns align with what the research literature predicts.
| Bleed Grade at Claim | Horses | Rest Period | Lasix Status | Returned to Form? | Avg. Starts Post-Claim | Outcome Summary |
|---|---|---|---|---|---|---|
| Grade 1–2 (confirmed scope) | 5 | 21–35 days | All on Lasix at return | 4 of 5 (80%) | 8.4 | Best ROI category. Three placed in first start back; one became a minor Louisiana-bred stakes contender. |
| Grade 2–3 (visible bleed) | 5 | 40–60 days | All on Lasix at return | 3 of 5 (60%) | 5.8 | Mixed results. Two returned to competitive form; one re-bled Grade 3 within 4 starts and was retired. Two performed below pre-bleed level despite Lasix. |
| Grade 3–4 (severe / barn bleed) | 2 | 60–90 days | Both on Lasix at return | 1 of 2 (50%) | 3.0 | One came back to win a $12,500 claimer. One re-bled Grade 4 on return and was retired. High risk, occasionally high reward. |
Note: Personal claiming outcomes in Louisiana’s overnight ranks, 2012–2024. Not a controlled study. Individual horse variation, trainer management, and race conditions all affect outcomes. Consult your veterinarian and review full past performance records before any claiming decision.
EIPH Bleeder Filter: $16,000 Claimer Betting Table
The table below represents the analysis framework I apply when reviewing bleeders in the $16,000 claiming ranks at Fair Grounds and Delta Downs. These are composite horse profiles based on real claiming patterns — not specific named horses. For the complete 4-point betting filter, see our dedicated guide. For wagering basics: how to bet on horse races.
| Profile Type | Bleed History | Lasix Status | Class Trend | Recent PP Pattern | Verdict |
|---|---|---|---|---|---|
| First-Time Lasix, No Bleed on Record | Suspected subclinical (trainer-initiated) | First Lasix today | Flat / slight drop | Late-race fade last 2 starts; no visible bleed | WATCH — Modest bounce possible; price often inflated by hype alone |
| Confirmed Bleeder, First Return on Lasix | Grade 2–3 visible bleed 6–8 weeks ago | Lasix today (first post-bleed start) | Class drop ($25k → $16k) | Pulled up or eased in bleed race; solid recent workout | PASS — Classic bounce-back setup; Lasix + class relief = legitimate runner |
| Chronic Grade 3+ Bleeder on Lasix | Multiple bleeds; Grade 3+ history | Lasix every start | Steady class drop over 6 months | Consistently fades 3/16 from wire; never closes | FADE — Lasix not fully controlling condition; likely progressing fibrosis |
| Stakes Bleed (No Lasix), Drops to Claimer | Bled in stakes race without Lasix | Lasix eligible today (claiming level) | Sharp class drop from stakes | Poor stakes finish attributed to bleed; solid works since | PASS — HISA rules created this angle; first time with Lasix at class-appropriate level |
| Maiden Bleeder, Second Career Start | Bled in maiden claiming debut | Lasix today (second career start) | Maiden claiming level | Only 1 career start; bleed noted in chart comments | WATCH — Too early to assess Lasix response; needs second start data |
| Older Claimer, Managed Stable Bleeder | Established Grade 1–2; managed 2+ years | Lasix every start, stable dosing | Stable at current level for 6+ months | Consistent mid-pack finishes; occasionally contends | PASS — Evaluate on form and pace; well-managed condition |
The popular perception is that first-time Lasix equals automatic speed figure improvement. The truth is more nuanced — and getting it right is where you find real betting edge.
If a horse has been a subclinical bleeder — Grade 1 or 2 — fading late without producing a visible nosebleed, managing that with Lasix can meaningfully improve late-race form. Those are the legitimate first-Lasix plays. You’re looking for: (1) a documented fade pattern in the final furlong, (2) the Lasix notation in the program, and (3) ideally a small class drop to reduce physical stress. All three together? That’s a real angle.
But some trainers put horses on Lasix because it’s available and legal — not because they’ve identified a bleeder. In those cases you’re paying for weight-loss benefit that rarely translates to a meaningful speed edge at the $16k claiming level. My rule from 30+ years at Fair Grounds: first-time Lasix + fade pattern + class drop = play. First-time Lasix alone = watch and collect data for next time.
Non-EIPH Nosebleed Causes in Racehorses: Rule These Out First
Not every nosebleed in a racehorse is EIPH. Before assuming a post-race bleed is pulmonary in origin, a thorough workup should systematically rule out other causes — some of which are more immediately dangerous and require completely different treatment.
Guttural Pouch Mycosis (GPM). The most dangerous cause of equine epistaxis and the first thing to rule out when blood is bright red, free-flowing, and not clearly correlated with exercise intensity. A fungal infection in the guttural pouches can erode major blood vessels — including the internal carotid artery — leading to catastrophic hemorrhage. A mild-seeming first bleed can be followed by a fatal second bleed within days. Emergency endoscopy and specialist referral are mandatory if GPM is suspected. See the PubMed GPM clinical review for full diagnostic detail.
Sinusitis and Respiratory Infections. EIV, EHV, and bacterial sinusitis weaken blood vessel walls in the sinuses and nasal passages. These bleeds typically present with mucoid or foul-smelling discharge alongside blood, plus fever and reduced appetite. These horses need antimicrobial or antiviral management — Lasix is not the answer here. For related reading, see why racehorses foam at the mouth.
Ethmoid Hematoma. A progressive, locally invasive accumulation within the ethmoid region — producing recurring unilateral epistaxis that is not exercise-correlated. Requires surgical or laser treatment and is distinct from EIPH in both presentation and management.
Trauma and External Injury. Gate accidents, head collisions, and foreign object inhalation produce localized bleeding typically from one nostril. Radiography may be needed to assess nasal bone integrity.
Coagulopathies. Clotting disorders — genetic, nutritional, or secondary to systemic disease — cause disproportionate bleeding from minor insults. A complete blood count (CBC), clotting factor panel, and platelet count are indicated when a horse bleeds unexpectedly or from minor exertion.
After Diamond Country’s Grade 3 bleed, my track vet at Fair Grounds walked me through a systematic protocol I now use with every horse in my barn. I share it here for educational purposes; your vet will tailor it to your specific situation.
- Step 1: Observe — one nostril or both? Bright red or darker? Mucus present?
- Step 2: Note exercise context — post-race, post-workout, or at rest?
- Step 3: Check vitals: temperature (fever = infection), respiratory rate, heart rate recovery curve.
- Step 4: Call the vet immediately. Do not wait for a second episode.
- Step 5: Endoscopy within 30–90 minutes post-exercise for accurate EIPH grading.
- Step 6: If GPM suspected (unilateral, bright red, not exercise-correlated): treat as emergency.
- Step 7: Request CBC and clotting panel if endoscopy is inconclusive.
- Step 8: Plan rest period and Lasix eligibility with track vet; confirm HISA rules for your race condition.
Educational only. Consult your licensed equine veterinarian for any diagnosis or treatment decisions.
What to Do If Your Racehorse Bleeds: Owner Action Checklist
Keep a copy of this checklist in your barn kit. If you see blood at your horse’s nostrils after a race or workout, here is your immediate action sequence.
Frequently Asked Questions: Why Do Racehorses Bleed From Lungs?
Why do racehorses bleed from the nose after a race?
In most cases, blood visible at the nostrils after a race is the result of Exercise-Induced Pulmonary Hemorrhage (EIPH) — bleeding that starts deep in the lung tissue where capillaries rupture under extreme cardiovascular pressure. Pulmonary arterial pressure can exceed 90–120 mmHg during peak effort versus 15–20 mmHg at rest, causing capillary stress failure. Blood enters the airways and, in severe Grade 3–4 cases, travels to the nostrils. Most EIPH is subclinical and produces no visible blood. A visible nosebleed indicates Grade 3–4 severity and warrants immediate veterinary evaluation, including endoscopy and a rule-out for guttural pouch mycosis.
Does EIPH hurt racehorses’ performance?
Yes, particularly at Grade 2 and above. Even subclinical bleeding reduces oxygen exchange efficiency, contributes to early fatigue, and impairs recovery. Horses with Grade 2–3 EIPH often show a quitting pattern in the final furlong — not from lack of fitness, but because compromised lung function limits sustained peak effort. Repeated EIPH episodes can cause progressive pulmonary fibrosis that compounds both the performance and welfare impact over a horse’s career.
Is Lasix banned for EIPH treatment in horse racing?
Under current HISA rules (as of March 2026), Lasix is banned in all stakes races and all two-year-old races in the United States. It remains permitted in overnight and claiming races under a three-year waiver. On May 22, 2026, HISA’s nine-member board is scheduled to vote on extending the ban to all races, and unanimous agreement is required to maintain the current rules. Internationally, race-day Lasix is banned in the majority of racing jurisdictions. Last verified: March 5, 2026.
How common is lung bleeding in racehorses?
60–95% of racehorses show EIPH signs after racing. The vast majority are Grade 1–2 events that produce no visible nosebleed. Visible epistaxis (Grade 4 EIPH) affects an estimated 1–5% of starts. Because most cases are subclinical, routine endoscopic monitoring — not just examinations after a visible bleed — is recommended for horses in active racing programs.
What does heavy pre-race urination mean for bleeders?
When a horse urinates heavily in the receiving barn before a race — often shedding 15–30 pounds of body weight — it usually indicates that Lasix is working as intended for EIPH management. The diuretic reduces circulating blood volume, which lowers pulmonary vascular pressure and reduces the likelihood and severity of lung bleeding during the race. For the complete explanation of the Lasix-urination-EIPH chain, see the guide on why racehorses pee so much before a race.
- Lasix In Horse Racing: Benefits, Risks, And Regulations — How furosemide affects performance, safety, and EIPH management.
- Why Do Racehorses Pee So Much? — Understanding Lasix-induced fluid loss and its link to EIPH prevention.
- Racehorse Nosebleeds: EIPH, Treatments & What To Do — Practical guidance for owners on spotting and managing bleeders.
- Weight Loss During a Race — How dehydration and pulmonary stress affect performance and EIPH risk.
- Racehorse Injuries: Types, Causes & Prevention — Broader context on musculoskeletal and respiratory risks in racehorses.
- Why Do Racehorses Sweat? — Insights into thermoregulation and its connection to exertional stress and lung health.
This article is educational only. Consult a licensed equine veterinarian for any diagnosis or treatment decision. HISA Lasix regulatory information is highly time-sensitive — verify before every race entry. All external links confirmed active as of March 5, 2026.
- ACVIM Consensus Statement on EIPH and Furosemide — PubMed (2015)
- 2024 Equine Veterinary Journal EIPH / Furosemide Study — PMC
- WSU 2024 Furosemide Racehorse Study — Washington State University
- HISA May 2026 Lasix Vote — Thoroughbred Daily News (Feb 2026)
- NYTHA 2026 Horsemen Survey on Lasix Ban Impact — Equibase
- Furosemide Research Overview — DVM360 (Feb 2026)
- Guttural Pouch Mycosis in Horses — PubMed
- Quantification of Exercise-Induced Pulmonary Haemorrhage — PubMed
About Miles Henry
Racehorse Owner & Author | 30+ Years in Thoroughbred Racing
Miles Henry (legal name: William Bradley) is a professional horseman based in Folsom, Louisiana. He holds Louisiana Racing License #67012 and has spent over three decades managing Thoroughbreds at premier tracks including Fair Grounds, Delta Downs, and Evangeline Downs.
Expertise & Hands-On Experience: Beyond the track, Miles has decades of experience in specialized equine care, covering everything from hoof health and nutrition to training protocols for Quarter Horses, Friesians, and Paints. Every guide on Horse Racing Sense is rooted in this “boots-on-the-ground” perspective.
30 of their last 90 starts
Equibase Profile.
Connect with Miles: